← Leaderboards
Matthew Sean Halquist
Virginia Commonwealth University
$1,629,321
Attributed
$2,840,322
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2019–23$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,840,322 · 2
By mechanism
UG3$1,614,668 · 1
P30$1,225,654 · 1
Top collaborators
- Frederick Gerard Moeller1 shared
- Charles O'Keeffe1 shared
- Qingguo Xu1 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Aron H Lichtman$10,846,349
- Jenny L. Wiley$18,479,501
- Richard A Glennon$4,822,005
- Gary L Bowlin$1,587,500
- David G Simpson$1,301,992
Others in their field
Other Emerging Leaders on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
- Yunda Huang · Fred Hutchinson Cancer Center$53,780,853
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Kathleen Maletic Neuzil · Emory University$27,014,427
Research focus
Drug KineticsTechnologyRouteMetabolismDosage FormsNational Institute Of Drug AbuseIn VitroPharmaceutical PreparationsDrug AbuseDetectionDimensions2-ArachidonylglycerolAnandamideDetectorDrug DispositionCotinineCommunitiesCoupledDesigner DrugsCannabidiolCannabimimeticsCannabinoidsAnalytical MethodApomorphine
Grant awards (6)
Bioanalytical Core$256,315
P30 · FY2023 · DA · contact PI
Bioanalytical Core$256,315
P30 · FY2022 · DA · contact PI
Bioanalytical Core$256,315
P30 · FY2021 · DA · contact PI
Bioanalytical Core$228,370
P30 · FY2020 · DA · contact PI
Novel LAAM formulations to treat Opioid Use Disorder (UG3 DA048768-01A1)$1,614,668
UG3 · FY2019 · DA
Bioanalytical Core$228,339
P30 · FY2019 · DA · contact PI